AI assistant
Sending…
Aquestive Therapeutics, Inc. — Director's Dealing 2018
Sep 13, 2018
32552_dirs_2018-09-13_d4182e17-90e2-48c9-9dae-c931a837ae86.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Aquestive Therapeutics, Inc. (AQST)
CIK: 0001398733
Period of Report: 2018-09-10
Reporting Person: BRAENDER LORI J (N/A)
More from Aquestive Therapeutics, Inc.
Annual Report
2026
Apr 24
Regulatory Filings
2026
Mar 30
Board/Management Information
2026
Mar 20
Investor Presentation
2026
Feb 26
Regulatory Filings
2026
Feb 2
Regulatory Filings
2026
Jan 21
Regulatory Filings
2026
Jan 9
Director's Dealing
2025
Dec 5
Director's Dealing
2025
Dec 4
Regulatory Filings
2025
Nov 17